Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Abcodia Ltd.
DescriptionRisk of ovarian cancer algorithm based on the change in CA-125 levels, genetics, family history and age
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDetect ovarian cancer
Regulatory Designation
PartnerMassachusetts General Hospital;
University of London

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today